| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |